Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Helix Acquisition Corp. II

Get SEC filing alerts via email and in your feed for Helix Acquisition Corp. II

HLXB

Helix Acquisition Corp. II

About Helix Acquisition Corp. II

Helix Acquisition Corp. II is a Cayman Islands-based special purpose acquisition company (SPAC) formed to identify and merge with target businesses. It has no operations or revenues, raising funds through an IPO and private placements. Its business model involves completing a merger or acquisition within a set timeframe, primarily targeting biotech or healthcare companies, with shareholder redemption rights and a focus on strategic, value-creating transactions.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Helix Acquisition Corp. II

1
1
Helix Acquisition Corp. II BridgeBio Oncology Reports $42.1M Net Loss and Increased R&D Expenses in Latest Filing

Via official filing (AI summary) | 23 days ago | 0 comments

2
1
Helix Acquisition Corp. II BridgeBio Oncology Reports $134 Million Net Loss for 2025, Increases R&D Spending by 66%

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Helix Acquisition Corp. II BridgeBio Oncology Reports $44.8M Net Loss in Q3 2025, Increases R&D Spending

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Helix Acquisition Corp. II Helix Acquisition Corp. II Reports Q2 2025 Financial Results, Faces Liquidity Challenges

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Helix Acquisition Corp. II Helix Acquisition Corp. II Reports Net Loss and Plans Merger with BridgeBio Oncology Therapeutics

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Helix Acquisition Corp. II Helix Acquisition Corp. II Reports $7.6M Net Income Turnaround, Plans Merger with BridgeBio Oncology

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Helix Acquisition Corp. II Helix Acquisition Corp. II Reports Financial Results for Period Ending September 30, 2024, with Strong Cash Position and Positive Net Income

Via official filing (AI summary) | over 1 year ago | 0 comments